AR

Aviko Radiopharmaceuticals

Europe, Lincolnshire, United Kingdom, New York

Description

Aviko Radiopharmaceuticals develops novel boron medicines that aids Boron Neutron Capture Therapy to Treat Cancer.

Investor Profile

Aviko Radiopharmaceuticals has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Health Care, Oncology.

Stage Focus

  • Series C (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Health Care
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Aviko Radiopharmaceuticals frequently co-invest with?

Cicada Innovations
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Macmillan Cancer Support
Europe, England, United Kingdom, London
Co-Investments: 1
Cone Health
North America, North Carolina, United States, Greensboro
Co-Investments: 1
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Wisconsin Alumni Research Foundation
North America, Wisconsin, United States, Madison
Co-Investments: 1
McLaren Health Care
North America, Michigan, United States, Grand Blanc
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1

What are some of recent deals done by Aviko Radiopharmaceuticals?

Leo Cancer Care

Harley, Surrey, United Kingdom

Leo Cancer Care constantly seeking to optimise and improve.

Health CareOncology
Series CJun 11, 2024